We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Biotech Growth Trust (the) Plc | LSE:BIOG | London | Ordinary Share | GB0000385517 | ORD 25P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.00 | -0.71% | 983.00 | 976.00 | 986.00 | 999.00 | 984.00 | 999.00 | 17,611 | 16:35:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Unit Inv Tr, Closed-end Mgmt | -32.42M | -41.3M | -1.0034 | -9.83 | 405.82M |
From Apr 2024 to May 2024
PR Newswire
LONDON, United Kingdom, May 03
The Biotech Growth Trust PLC
(the "Company")
Compliance with Market Abuse Regulation
3 May 2024
The Company confirms that:
a) all inside information which the Directors and Company may have had has been notified to a Regulated Information Service ("RIS");
b) the Company's net asset value per share is calculated and announced through a RIS on a daily basis;
c) the Company has no reason to believe that there will be any material difference between the net asset value per share as at close of business on Thursday, 28 March 2024, which was announced on Tuesday, 2 April 2024, and the financial information to be published in the announcement of its results for the year ended 31 March 2024.
The Company is, therefore, not prohibited from dealing in its own securities during the closed period, as defined by the UK Market Abuse Regulation, which will end on the date of the publication of its results for the year ended 31 March 2024, expected to be on or after Wednesday, 5 June 2024.
-ENDS-
For further information please contact:
Katherine Manson Frostrow Capital LLP - 0203 709 8734
1 Year Biotech Growth Chart |
1 Month Biotech Growth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
